Verified· 2 sources

Xeltis AG

Summary

About the company

The core activity of Xeltis is the development and manufacturing of medical implants, particularly for the treatment of cardiovascular diseases, such as heart valves and vessels. The company focuses on developing innovative, bioresorbable materials and technologies to improve patient care in this field.

AI-generated

Offering

Products & services

Industry:Medical Technology Industry

✓ Offered5

Vascular implant for hemodialysis access (aXess™)

Vascular implant and access channel for hemodialysis, implanted in a procedure, with early possible cannulation and later conversion into a living vessel.

Endogenous Tissue Restoration (ETR) Platform

Bioresorbable supramolecular polymer platform that, through the body's own cell infiltration, generates living tissue and is replaced over time by its own vascular or valve tissue.

Coronary artery bypass conduit (XABG)

Restorative bypass connector for coronary heart disease, developed to maintain blood flow and to progressively form a long-term living vessel.

Pulmonary heart valve replacement (Xplore-2)

Restorative pulmonary heart valve intended to transform into a living valve made of patient-derived tissue, with an ongoing clinical study in Europe and the USA.

Clinical studies on vascular implants

Clinical programs and studies on aXess, XABG/CABG and Xplore-2 to assess safety, performance, patency and tissue transformation.

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

Xeltis AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

Xeltis AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

No knowledge articles yet

Xeltis AG in comparison

Industry comparisons are coming soon

Similar companies